Hypoxic fetoplacental vasoconstriction in humans is mediated by potassium channel inhibition
Hypoxic fetoplacental vasoconstriction in humans is mediated by potassium channel inhibition
复制标题
DOI:
10.1152/ajpheart.01033.2001
复制
发表时间:
2002-12-01
影响因子:
4.8
通讯作者:
Archer, SL
中科院分区:
文献类型:
--
作者:
Hampl, V;Bíbová, J;Archer, SL
Fetal to maternal blood flow matching in the placenta, necessary for optimal fetal blood oxygenation, may occur via hypoxic fetoplacental vasoconstriction (HFPV). We hypothesized that HFPV is mediated by K+ channel inhibition in fetoplacental vascular smooth muscle, as occurs in several other O-2-sensitive tissues. With the use of an isolated human placental cotyledon perfused at a constant flow rate, we found that hypoxia reversibly increased perfusion pressure by >20%. HFPV was unaffected by cyclooxygenase or nitric oxide synthase inhibition. HFPV and 4-aminopyridine, an inhibitor of voltage-dependent K+ (K-v) channels, increased pressure in a nonadditive manner, suggesting they act via a common mechanism. Iberiotoxin, a large conductance Ca2+- sensitive K+ (BKCa) channel inhibitor, had little effect on normoxic pressure. Immunoblotting and RT-PCR showed expression of several putative O-2-sensitive K+ channels in peripheral fetoplacental vessels. In patch-clamp experiments with smooth muscle cells isolated from peripheral fetoplacental arteries, hypoxia reversibly inhibited K-v but not BKCa or ATP-dependent currents. We conclude that human fetoplacental vessels constrict in response to hypoxia. This response is largely mediated by hypoxic inhibition of K-v channels in the smooth muscle of small fetoplacental arteries.